All In Biotech

Free tool

FAERS Monitor: Yasmin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021098 or its brand name (Yasmin, Drospirenone, Ethinyl Estradiol). Reports on generic versions are filed under their own applications.

Reports

24,602

Serious

21,826

89% of reports

Hospitalization

12,693

Death reported

428

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pain8,959
  • injury7,736
  • pulmonary embolism5,825
  • deep vein thrombosis5,609
  • anxiety4,646
  • emotional distress4,574
  • cholecystitis chronic3,785
  • cholelithiasis2,794
  • gallbladder disorder2,760
  • general physical health deterioration2,324
  • abdominal pain1,739
  • nausea1,652
  • anhedonia1,554
  • thrombosis1,419
  • dyspnoea1,338

Reports by year received

View as table
YearReports
2004199
2005284
2006322
2007329
20081,375
2009705
20101,404
20116,766
20126,083
20133,245
20141,658
2015489
2016267
2017163
2018190
2019188
2020180
2021127
2022144
2023164
2024127
202599
202694

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,029,557 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
cholecystitis chronicSignal3,7851108.41057.91,823,462
gallbladder disorderSignal2,760156.1150.2359,880
injurySignal7,736105.6103.5715,502
deep vein thrombosisSignal5,60980.778.7404,427
cholelithiasisSignal2,79479.576.7198,462
pulmonary embolismSignal5,82555.854.5295,331
anhedoniaSignal1,55453.751.175,615
emotional distressSignal4,57433.532.6139,669
general physical health deteriorationSignal2,32417.516.835,616
thrombosisSignal1,41915.314.618,730
anxietySignal4,64614.213.856,704
painSignal8,95912.612.497,454
abdominal painSignal1,7396.46.18,000
dyspnoeaSignal1,3382.01.9709
nausea1,6521.81.7592

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.